1,1',3,3',5,5',6,6'-Octamethyl-1,1',3,3'-tetrahydro-2,2'-spirobi[benzo[d]imidazole]

Catalog No. :
ACSSND004
CAS No. :
99643-38-6
Molecular Formula :
C21H28N4
Molecular Weight :
336.48

IUPAC Name:1,1',3,3',5,5',6,6'-octamethyl-1,1',3,3'-tetrahydro-2,2'-spirobi[benzo[d]imidazole]

1,1',3,3',5,5',6,6'-Octamethyl-1,1',3,3'-tetrahydro-2,2'-spirobi[benzo[d]imidazole] structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,1',3,3',5,5',6,6'-Octamethyl-1,1',3,3'-tetrahydro-2,2'-spirobi[benzo[d]imidazole]
IUPAC Name1,1',3,3',5,5',6,6'-octamethyl-1,1',3,3'-tetrahydro-2,2'-spirobi[benzo[d]imidazole]
Molecular FormulaC21H28N4
Molecular Weight336.48
SMILESCC1=C(C)C=C(N2C)C(N(C)C32N(C)C4=CC(C)=C(C)C=C4N3C)=C1
InChI KeyMTFYBWKFOIZUKS-UHFFFAOYSA-N
Synonym1,13,3,5,56,6-Octamethyl-2,2-spiro(2,3-dihydro-1H-benzimidazole;1,1',3,3',5,5',6,6'-octaMethyl-2,2'-spirobi<2,3-dihydro-1H-benziMidazole>;1,1',3,3',5,5',6,6'-octamethyl-2,2'-spirobi[benzimidazole];4S Green Nucleic Acid Stain;4S Green Nucleic Acid Stain 4S Green;2,2'-Spirobi[2H-benzimidazole], 1,1',3,3'-tetrahydro-1,1',3,3',5,5',6,6'-octamethyl-;1,13,3,5,56,6-Octamethyl-2,2-spiro(2,3-dihydro-1H-benzimidaz
CAS No.99643-38-6

Synthetic Route by SureRoute

1. ACSSND004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSSND004 route product structure diagram
    ACSSND00499643-38-6
Inquiry

2. ACSSND004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSSND004 route product structure diagram
    ACSSND00499643-38-6
Inquiry

Comments (0)